Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report)’s stock price dropped 6.4% during trading on Wednesday . The company traded as low as $17.68 and last traded at $17.68. Approximately 1,000 shares traded hands during trading, a decline of 63% from the average daily volume of 2,695 shares. The stock had previously closed at $18.8815.
Shionogi & Co., Ltd. Price Performance
The stock has a fifty day moving average of $19.36 and a 200-day moving average of $19.15.
About Shionogi & Co., Ltd.
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
Featured Articles
- Five stocks we like better than Shionogi & Co., Ltd.
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
